Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression | Zendy

Virginie Supervie | Zendy; Lambert Assoumou | Zendy; Romulus Breban | Zendy; F. Lert | Zendy; Dominique Costagliola | Zendy; Gilles Pialoux | Zendy; Roland Landman | Zendy; PierreMarie Girard | Zendy; Laurence Slama | Zendy; André Cabie | Zendy; Sylvie Abel | Zendy; Patrick Hochedez | Zendy; Sandrine Pierre-François | Zendy; Benoît Rozé | Zendy; Anne Simon | Zendy; Catherine Lupin | Zendy; Christine Katlama | Zendy; M. A. Valentin | Zendy; Brigitte Autran | Zendy; Assia Samri | Zendy; Sidonie Lambert | Zendy; AnneGeneviève Marcelin | Zendy; Véronique Joly | Zendy; Zélie Julia | Zendy; Stanislas Harent | Zendy; Emmanuelle Papot | Zendy; Bao-Chau Phung | Zendy; Gilles Peytavin | Zendy; Patrick Lê Minh | Zendy; Agathe Rami | Zendy; Myriam Diemer | Zendy; Maguy Parrinello | Zendy; Isabelle Cahitte | Zendy; Feng Zeng | Zendy; E. Mortier | Zendy; Thomas L’Yavanc | Zendy; Guillaume Loup | Zendy; Philippe Bonnard | Zendy; Marie Gisèle Lebrette | Zendy; J. Chas | Zendy; V Berrebi | Zendy; N. Velazquez | Zendy; Anne Adda | Zendy; Claudine Duvivier | Zendy; Fatima Touam | Zendy; Olivier Lortholary | Zendy; Michka Shoai-Tehrani | Zendy; Claire Rouzaud | Zendy; É. Denes | Zendy; Sophie Ducroux-Roubertou | Zendy; H. Durox | Zendy; Claire Genet | Zendy; Jean-Philippe Rogez | Zendy; Sylvie RangerRogez | Zendy; José M. Pascual | Zendy; Laurence Weiss | Zendy; Juliette Pavie | Zendy; E Bourzam | Zendy; Hugues Aumaître | Zendy; Milagros Ferreyra | Zendy; Matthieu Saada | Zendy; Martine Malet | Zendy; Christia Palacios | Zendy; P. Honoré | Zendy; Irène Zamord | Zendy; Huguette Berthé | Zendy; Stéphanie Landowski | Zendy; Pierre de Truchis | Zendy; Philippe Perre | Zendy; Nadia Valin | Zendy; Pauline Campa | Zendy; Bénédicte Lefebvre | Zendy; Jean-Luc Meynard | Zendy; Michèle Pauchard | Zendy; Laure Surgers | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression

Author(s) -

Virginie Supervie,

Lambert Assoumou,

Romulus Breban,

F. Lert,

Dominique Costagliola,

Gilles Pialoux,

Roland Landman,

PierreMarie Girard,

Laurence Slama,

André Cabie,

Sylvie Abel,

Patrick Hochedez,

Sandrine Pierre-François,

Benoît Rozé,

Anne Simon,

Catherine Lupin,

Christine Katlama,

M. A. Valentin,

Brigitte Autran,

Assia Samri,

Sidonie Lambert,

AnneGeneviève Marcelin,

Véronique Joly,

Zélie Julia,

Stanislas Harent,

Emmanuelle Papot,

Bao-Chau Phung,

Gilles Peytavin,

Patrick Lê Minh,

Agathe Rami,

Myriam Diemer,

Maguy Parrinello,

Isabelle Cahitte,

Feng Zeng,

E. Mortier,

Thomas L’Yavanc,

Guillaume Loup,

Philippe Bonnard,

Marie Gisèle Lebrette,

J. Chas,

V Berrebi,

N. Velazquez,

Anne Adda,

Claudine Duvivier,

Fatima Touam,

Olivier Lortholary,

Michka Shoai-Tehrani,

Claire Rouzaud,

É. Denes,

Sophie Ducroux-Roubertou,

H. Durox,

Claire Genet,

Jean-Philippe Rogez,

Sylvie RangerRogez,

José M. Pascual,

Laurence Weiss,

Juliette Pavie,

E Bourzam,

Hugues Aumaître,

Milagros Ferreyra,

Matthieu Saada,

Martine Malet,

Christia Palacios,

P. Honoré,

Irène Zamord,

Huguette Berthé,

Stéphanie Landowski,

Pierre de Truchis,

Philippe Perre,

Nadia Valin,

Pauline Campa,

Bénédicte Lefebvre,

Jean-Luc Meynard,

Michèle Pauchard,

Laure Surgers

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx276

Subject(s) - serostatus , cart , medicine , immunosuppression , men who have sex with men , viral load , human immunodeficiency virus (hiv) , transmission (telecommunications) , antiretroviral therapy , virology , mechanical engineering , electrical engineering , syphilis , engineering

Individuals presenting for care with severe immunosuppression typically have high plasma HIV viral load (pVL) and may transmit HIV before and after initiation of combination antiretroviral therapies (cART).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research